Cross-Sector entity
Adam Alanoff is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. The clearest coverage concentration is market-trends: 1 of 2 stories, with the rest divided among 1 other category. Each carries 2 original sources on average.
2 verified stories tracked
Last mentioned: Feb 26, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Adam Alanoff is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. The clearest coverage concentration is market-trends: 1 of 2 stories, with the rest divided among 1 other category. Each carries 2 original sources on average. We currently track 2 Cross-Sector stories that mention Simon May, all published on February 26, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Simon May. Shared-story counts are live from our verified record — not editorial picks.
Agilent reported a 4.4% core revenue growth in Q1 2026, driven by a strong 7% uptick in the pharmaceutical sector despite an 8% decline in academic and government markets. The company is navigating margin pressures from new tariffs while leaning into high-growth areas like GLP-1 manufacturing and CDMO services.
Agilent Technologies reported a resilient Q1 2026 with $1.8 billion in revenue, driven by a 7% growth in the pharma sector despite significant headwinds in academic and government funding. While the company faced a 100-basis-point gross margin compression due to rising tariffs and weather disruptions, strong performance in the Agilent CrossLab Group suggests a shift toward service-oriented recurring revenue.
Source: Motley Fool Transcribing (us) · Motley Fool Transcribing (us)
